Principal Investigator/Program Director: Oebas, HaUe T. / Schambelan, MorrisROLE OF NICOTINE IN SMOKING-INDUCED CARDIOVASCULAR DISEASE (Full text located at page 469)Principal Investigator: Neal Benowitz, MD (Biographical sketch begins on page 78)Co-Investigator: Delia Dempsey, MD (Biographical sketch begins on page 118)SOURCES OF SUPPORT FOR INVESTIGATORS:* Denotes funding that directly supports this study.Neal BenowitzGrant Number:Grant Title:Principal Investigator:Percent Effort:Inclusive Dates:Annual Dollar Amount:Grant Number:Grant Title:Principal Investigator:Percent Effort:Inclusive Dates:Annual Dollar Amount:Grant Number:Grant Title:Principal Investigator:Percent Effort:Inclusive Dates:Annual Dollar Amount:Grant Number:Grant Title:Principal Investigator:Percent Effort:Inclusive Dates:Annual Dollar Amount:Grant Number:Grant Title:Principal Investigator:Percent Effort:Inclusive Dates:Annual Dollar Amount:Grant Number:Grant Title:Principal Investigator:Percent Effort:Inclusive Dates:Annual Dollar Amount:R37 DA02277-23, NIDA *PharmacokineUcs/Pharmacodynamics of NicotineBenowitz25%311179-6130103$355,984R01 CA78603-03, NCISafety of a Nicotine Reduction StrategyBenowitz15%611199-3131103$402,313P30 CA82103-02, NCICancer Center Support GrantMcCormick5%815199-7131102$868,796R01 DA11170-04, NIDA, Subcontract (17-000217) to Stanford ResearchInstitutePharmacokinetics of Nicotine in TwinsBenowitz10%6/1/99-2/28/03$124,8297PT-2004, NIDATobacco-Related Disease Research Program Nicotine Metabolism in FamiliesBenowitz5%711199-6130102$160,439T32 GM07546-24, NIHClinical Pharmacology, Drug Action and PharmacokineticsBenowitz5%711192-6130105$140,682Page t z,4'/
Showing the most recent 10 out of 553 publications